Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,748 total articles
Krystal Biotech announced its participation in the 2026 Cantor Global Healthcare Conference where management will conduct a fireside chat and investor meetings. The company, a commercial-stage biotech specializing in genetic medicines, aims to showcase its innovative therapies such as VYJUVEK® and its growing pipeline to potential investors.
LB Pharmaceuticals has appointed Joseph Miller as Chief Financial Officer. Miller brings over 20 years of biopharmaceutical finance experience, including successful commercialization of a novel therapy. His expertise aims to support LB Pharmaceuticals as it approaches critical Phase 3 trial results for LB-102, a potential first benzamide antipsycho…
Tectonic Therapeutic, Inc., a clinical-stage biotechnology company specializing in therapeutic proteins and antibodies targeting GPCRs, announced that its CEO, Alise Reicin, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The event will provide insights into the company's proprietary GEODe platfor…
Jyong Biotech Ltd., a Nasdaq-listed biotechnology company focused on plant-derived therapeutics for urinary system diseases, announced its participation in the StockFan Virtual Investor Non-Deal Roadshow scheduled for September 6-7, 2026. The event aims to engage investors, analysts, and media across multiple time zones with presentations in both M…
Kustom Entertainment, Inc. provided a detailed operational update on its pending acquisition of TFL, LLC (Tickets For Less), highlighting TFL's diversified and high-margin revenue streams exceeding $238 million in 2025. The integration is expected to unify ticketing infrastructure with Kustom's TicketSmarter platform, internalize ticketing margins …
Satellogic has announced that all maritime intelligence derived from its upcoming Merlin satellite constellation will be exclusively distributed through SynMax's Theia platform. The Merlin constellation, launching in October 2026, offers daily global coverage at one-meter resolution to enhance vessel detection, dark-vessel identification, sanctions…
Stereotaxis' Genesis Robotic Magnetic Navigation system was used to treat over 70 arrhythmia patients at the University of Szeged within one month of launching their robotic cardiology program, marking Hungary's first such program and demonstrating rapid adoption and advanced treatment capabilities.
3 E Network Technology Group Limited announced a $1 million private placement led by its CEO, Dr. Tingjun Yang, to strengthen its AI strategy. The capital will support ongoing R&D and commercialization of AI computing chips and applications. Recent milestones include advancements in edge AI SoCs, cloud AI storage controllers, a green AI data center…
AGM Group Holdings Inc. announced that their full-stack AI storage solutions are gaining market traction, driven by rising demand for high-performance data storage used in large AI model R&D and cloud services. The company has started mass production of all-flash servers and has secured procurement agreements with enterprise and regional computing …
Emergent BioSolutions has completed a repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028, reducing the outstanding debt balance to approximately $364.7 million. The company executed this repurchase at an average price of 90.6% of face value, deploying about $68 million of cash, demonstrating disciplin…
Hillman Solutions Corp., a leading hardware product provider, has completed its acquisition of Kanebridge, LLC, a master distributor of industrial fasteners, for approximately $315 million. This strategic move significantly expands Hillman's industrial addressable market to around $3 billion and establishes its first U.S. master distribution platfo…
Helus Pharma announced that CEO Michael Halstead will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York. The company is advancing its clinical-stage programs for proprietary serotonergic agonists aimed at treating depression and anxiety, including a Phase 3 candidate with FDA Breakthrough Therapy Designation…
The FDA has granted Fast Track designation to Liquidia Corporation's inhaled powder drug YUTREPIA (treprostinil) for the treatment of Raynaud's phenomenon associated with systemic sclerosis (SSc-RP), a condition with significant unmet medical need and no approved therapies in the United States. This designation will help expedite the development an…
Crescent Biopharma, a clinical-stage biotech company focusing on innovative cancer therapies, announced its management will present at the 2026 Cantor Global Healthcare Conference and Morgan Stanley Global Healthcare Conference in September. The presentations will highlight the company's pipeline developments including a PD-1 x VEGF bispecific anti…
Structure Therapeutics, a clinical-stage biopharmaceutical company focused on oral small molecule therapeutics for metabolic diseases, will participate in three leading healthcare investment conferences in September 2026, including Cantor Global Healthcare, Morgan Stanley Global Healthcare, and Bernstein’s Healthcare Forum. Management will hold fir…
TG Therapeutics announced that CEO Michael S. Weiss will participate in a fireside chat at the Cantor Global Healthcare Conference on September 9, 2026. The company is a commercial-stage biotech focused on treatments for B-cell diseases, with its FDA-approved drug BRIUMVI for relapsing multiple sclerosis.
Rekor Systems, Inc. has terminated its two remaining long-term real estate leases in the US and Israel, resulting in elimination of ongoing rent obligations and generating over $2 million in annual cost savings. The company used $2.8 million in cash to reduce $10 million in lease liabilities, improving operating leverage and aligning cost structure…
Electra Battery Materials Corporation is progressing with the construction of Canada’s only cobalt sulfate refinery in Ontario as part of its strategic plan to strengthen North America's critical minerals supply chain. The company is actively engaging with investors, industry participants, and government bodies through multiple September conference…
Eikon Therapeutics announced the appointment of Dr. Ching-Pin Chang as Executive Vice President and Chief Scientific Officer. Dr. Chang brings over 20 years of experience in academic medicine and biopharmaceutical drug discovery, having held key roles at Bristol Myers Squibb, Gilead Sciences, and MyoKardia. His extensive expertise in translational …
Trevi Therapeutics announced that senior executives will participate in several major healthcare and IPF-related conferences in September 2026, presenting updates on their investigational therapy Haduvio™ (oral nalbuphine ER) intended to treat chronic cough associated with IPF, non-IPF ILD, and refractory chronic cough. The company highlighted the …
Dyne Therapeutics announced preclinical data supporting the development of four novel investigational therapies targeting Duchenne Muscular Dystrophy (DMD) mutations amenable to exon skipping of 44, 45, 53, and 55. These candidates, based on the same FORCE™ platform as their lead drug under FDA review, demonstrated promising in vitro and in vivo re…
Saia, Inc. releases its less-than-truckload (LTL) shipment and tonnage data for July and August 2026, showing increases in shipments per workday, tonnage per workday, and weight per shipment compared to the same months in 2025. These gains indicate solid operational performance in the third quarter so far, though the company cautions actual results…
Alterity Therapeutics, a biotechnology company focused on neurodegenerative diseases, announced that CEO David Stamler will participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026. The company is preparing for a Phase 3 pivotal trial for its lead drug ATH434, which has shown promising results in Phase 2 trials for Multiple Sy…
Amwell received Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for its unified technology platform that addresses healthcare fragmentation by integrating consumer experiences, clinician workflows, care programs, and partner solutions. The award highlights Amwell’s innovation and business impact in creating a connected infrastr…
GXO Logistics, Inc. has expanded its technology organization by appointing Balaji Rangaswamy as Chief Information Officer. The restructuring focuses on enhancing the company's enterprise systems to support scalable growth and resilience while accelerating innovation, particularly in areas like AI and robotics. This move underlines GXO's commitment …
